6 min listen
GeoVax (GOVX) CEO On Developing A Covid-19 Vaccine
FromSchwab Network
ratings:
Length:
7 minutes
Released:
Nov 24, 2021
Format:
Podcast episode
Description
GeoVax (GOVX) stock is down around 11% in the last 5 days. Chairman and CEO, David Dodd, says that the clinical stage biotech company develops immunotherapies and vaccines against cancers and infectious diseases. GeoVax has Covid-19 trials for immunocompromised patients and a booster for MRNA treatment.
Released:
Nov 24, 2021
Format:
Podcast episode
Titles in the series (100)
CEO of Super League Gaming, Ann Hand Discusses The State Of Esports During The Pandemic by Schwab Network